Abacavir has a modest interaction profile. It is not processed by the liver enzyme system responsible for most HIV drug interactions, so the list is short and mostly manageable.
Why does it interact relatively little?
Because it is metabolised by different pathways from the CYP3A4 enzyme that causes most trouble in HIV medicine. It neither inhibits nor strongly induces that enzyme, so it does not raise or lower levels of most other medicines.
What about alcohol?
The interaction people find surprising. Alcohol raises abacavir levels somewhat, because the two are handled by an overlapping enzyme pathway. The effect is modest and rarely clinically significant, and heavy regular drinking is worth mentioning so it can be factored in.
Does that mean you should not drink?
No. Moderate drinking is not a problem with abacavir. The more relevant concerns with alcohol are missed doses, vomiting shortly after a dose, and liver health generally, particularly for anyone with hepatitis B or C.
What about methadone?
Abacavir can increase methadone clearance, which occasionally means a dose adjustment is needed. Anyone on a methadone programme should make sure both prescribers know about the other, since the adjustment is straightforward once identified.
What about rifampicin?
It may reduce abacavir levels somewhat, and the effect is less pronounced than with many other antiretrovirals. Where tuberculosis treatment is needed, the whole regimen is reviewed rather than one component adjusted.
Does it interact with hormone therapy?
No, in either direction. Abacavir does not affect oestradiol or testosterone levels, and gender-affirming hormone therapy does not reduce its effectiveness. Other components of a combination tablet may differ, so check the whole regimen.
What about recreational drugs?
No significant interaction. Abacavir does not block the enzyme that clears MDMA, methamphetamine, mephedrone or ketamine, unlike boosted regimens containing ritonavir or cobicistat. That is a genuine advantage worth knowing about.
What about antacids and supplements?
Fine. Abacavir is not bound by calcium, magnesium, iron or zinc, so no spacing is required. If your combination tablet contains dolutegravir, that component does need spacing from those minerals.
What about anti-inflammatory painkillers?
No particular concern, since abacavir does not burden the kidneys. This is one of the areas where abacavir-based regimens are simpler than tenofovir-based ones.
What about other HIV medicines?
The important rule is that abacavir should not be combined with certain other nucleoside analogues where the combination adds nothing, and regimens are constructed to avoid overlap. This is handled when the regimen is designed rather than something to manage yourself.
How do you check a combination?
The University of Liverpool interaction checker covers antiretrovirals against prescription, over-the-counter and recreational drugs, and is what clinicians use. A clinic pharmacist will check without an appointment in a couple of minutes.
What about things you would not think of as medicines?
Herbal remedies, particularly St John's wort, high-dose supplements and products bought online all count, as do medicines from a dentist or hospital team who cannot see your HIV record. If you swallow it, inject it or apply it regularly, mention it.
What about medicines from another doctor?
Tell whoever prescribes that you take it. GPs, dentists and hospital teams cannot see your HIV record, so the responsibility for mentioning it sits with you. A photograph of your packaging makes this quicker.
Does it affect contraception?
No. Abacavir does not reduce the effectiveness of hormonal contraception. Where a regimen contains a booster, that component may, so the question is about the whole combination rather than this drug.
Who should know what you take?
Your GP if you have consented to sharing, any hospital team treating you, your dentist, and any pharmacy dispensing anything else. None of them see your HIV record automatically, so nobody will flag an interaction with abacavir unless you mention it.
What about interactions you cannot avoid?
Sometimes another condition genuinely requires a drug that clashes. The answer is usually to change the HIV regimen rather than to leave the other condition untreated, and that is a conversation worth starting rather than accepting a compromise.